3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
2
Sarcoma
1
Conditions
Gliosarcoma
6
Glioblastoma
6
Brain Neoplasms
4
Sarcoma, Alveolar Soft Part
3
Sarcoma
3
Neoplasms
2
Carcinosarcoma
2
Waldenstrom Macroglobulinemia
1
Sezary Syndrome
1
Recurrence
1
Rectal Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Oligodendroglioma
1
Mycosis Fungoides
1
Melanoma
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Large Granular Lymphocytic
1
Leukemia, Hairy Cell
1
Leiomyosarcoma
1
Interventions
Paclitaxel
7
Specimen Handling
6
Radiotherapy
4
Magnetic Resonance Spectroscopy
4
Biopsy
4
pembrolizumab
3
Taxes
3
Nivolumab
3
Carboplatin
3
trastuzumab deruxtecan
2
olaparib
2
ceralasertib
2
aflibercept
2
X-Rays
2
Psychiatric Rehabilitation
2
Irinotecan
2
Ipilimumab
2
Immunoglobulin G
2
Ifosfamide
2
Gene Expression Profiling
2
Fulvestrant
2
Filgrastim
2
Fentanyl
2
Doxorubicin
2
Bevacizumab
2
trifluridine tipiracil drug combination
1
toripalimab
1
tinostamustine
1
spartalizumab
1
selinexor
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Endometrial Neoplasms
×
cediranib
×
Sarcoma
×
Clear all
NCT03570437
2022-03-02
COPELIA
University of Manchester
Phase 2
Unknown
124 enrolled